CPC
Cookson Peirce & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,719
| Closed | -$833K | – | 323 |
|
|
2025
Q1 | $833K | Sell |
1,719
-146,061
| -99% | -$70.8M | 0.04% | 163 |
|
|
2024
Q4 | $59.5M | Sell |
147,780
-7,301
| -5% | -$2.94M | 2.7% | 8 |
|
|
2024
Q3 | $72.1M | Sell |
155,081
-1,088
| -0.7% | -$506K | 3.38% | 4 |
|
|
2024
Q2 | $73.2M | Buy |
156,169
+13,187
| +9% | +$6.18M | 3.52% | 4 |
|
|
2024
Q1 | $59.8M | Sell |
142,982
-1,026
| -0.7% | -$429K | 3.19% | 6 |
|
|
2023
Q4 | $58.6M | Sell |
144,008
-2,893
| -2% | -$1.18M | 3.54% | 5 |
|
|
2023
Q3 | $51.1M | Buy |
146,901
+333
| +0.2% | +$116K | 3.35% | 4 |
|
|
2023
Q2 | $51.6M | Buy |
146,568
+7,996
| +6% | +$2.81M | 3.15% | 6 |
|
|
2023
Q1 | $43.7M | Buy |
138,572
+19,457
| +16% | +$6.13M | 2.8% | 6 |
|
|
2022
Q4 | $34.4M | Buy |
119,115
+59,543
| +100% | +$17.2M | 2.24% | 12 |
|
|
2022
Q3 | $17.2M | Buy |
59,572
+46,137
| +343% | +$13.4M | 1.22% | 35 |
|
|
2022
Q2 | $3.79M | Sell |
13,435
-784
| -6% | -$221K | 0.26% | 75 |
|
|
2022
Q1 | $3.71M | Buy |
14,219
+682
| +5% | +$178K | 0.22% | 82 |
|
|
2021
Q4 | $2.97M | Buy |
+13,537
| New | +$2.97M | 0.17% | 85 |
|
|
2020
Q4 | – | Sell |
-159,556
| Closed | -$43.4M | – | 187 |
|
|
2020
Q3 | $43.4M | Buy |
159,556
+19,077
| +14% | +$5.19M | 3.26% | 4 |
|
|
2020
Q2 | $40.8M | Buy |
140,479
+1,586
| +1% | +$460K | 3.83% | 4 |
|
|
2020
Q1 | $33.1M | Buy |
+138,893
| New | +$33.1M | 3.8% | 2 |
|
|
2018
Q2 | – | Sell |
-9,740
| Closed | -$1.59M | – | 167 |
|
|
2018
Q1 | $1.59M | Buy |
9,740
+1,690
| +21% | +$275K | 0.14% | 74 |
|
|
2017
Q4 | $1.21M | Buy |
8,050
+760
| +10% | +$114K | 0.11% | 81 |
|
|
2017
Q3 | $1.11M | Buy |
+7,290
| New | +$1.11M | 0.11% | 84 |
|